Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
Quick Stats
Feb 02, 202651.4
AI Score
HOLD0.77
Volume Ratio
Feb 25, 2026
Next Earnings
12
+ve Days (30d)
17
-ve Days (30d)
KURA Stock Summary
Last updated Feb 02, 2026
KURA is currently trading at $8.27, positioned above its 200-day moving average of $8.15, indicating a long-term uptrend. The stock has a 52-week range of $5.41 to $12.49.
Technical Analysis: The 50-day moving average stands at $10.15, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 36.601, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.156, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates KURA at 51.4/100 with a HOLD recommendation.
KURA (Kura Oncology, Inc.) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 36.601 |
| CMF (20) | -0.156 |
| ROC (10) | -2.246 |
| ADX (14) | 23.713 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.541 |
| AROONOSC (14) | -71.429 |
| WILLAMS %R (14) | -82.269 |
| MFI (14) | 28.499 |
KURA Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
KURA Price vs Max Options Open Interest
KURA Max Change In Options Open Interest
KURA Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KURA Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KURA Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KURA Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Kura Oncology, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
KURA Moving Averages Analysis
Kura Oncology, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 02, 2026
KURA (Kura Oncology, Inc.) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 8.47 |
| 20 | 8.89 |
| 30 | 9.43 |
| 50 | 10.15 |
| 100 | 9.87 |
| 200 | 8.15 |
KURA Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 706.6 million |
| Earnings/Share ($) | -2.48 |
| Net Proft Margin (%) | -2.0848 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -2.4878 |
| EPS Estimate Next Year ($) | -2.6044 |
| WallStreet Target Price ($) | 32.5455 |
| Most Recent Quarter |